Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference
October 25, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery Disease
April 13, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 13, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics' PRT-201 in Peripheral Artery Disease
January 08, 2015 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Pricing of Initial Public Offering
October 21, 2014 19:36 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc., a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and...
Pomona Valley Hospital Medical Center Unveils Life-Saving Tools for Victims of Stroke and Other Vascular Conditions
June 09, 2014 15:08 ET
|
Pomona Valley Hospital Medical Center - MNews
POMONA, Calif., June 9, 2014 (GLOBE NEWSWIRE) -- The chance of surviving a stroke can be increased if the victim gets help right away. Today, Pomona Valley Hospital Medical Center (PVHMC) announced...
TissueGen Enhances Intellectual Property Portfolio With New Patent for Self-Expanding Medical Device
April 29, 2014 10:00 ET
|
TissueGen Inc.
DALLAS, TX--(Marketwired - Apr 29, 2014) - TissueGen® Inc., developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic...
VENITI, Inc. Announces First Uses of Veniti Vici Venous Stent System
January 23, 2014 17:07 ET
|
VENITI, Inc.
ST. LOUIS, Jan. 23, 2014 (GLOBE NEWSWIRE) -- VENITI announced today that patients in the European Union (EU) were successfully treated for symptomatic venous outflow obstruction of the lower...
Peripheral Vascular Devices - Emerging Markets 2009-2015
October 29, 2013 11:52 ET
|
Research and Markets
Dublin, Oct. 29, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/rdbx62/peripheral)
has announced the addition of the "Peripheral
Vascular Devices -...